Prodigiosin As N-heterocyclic compound: Production optimization, bioactivity evaluation, and in-silico docking against key enzymes related to inflammation, obesity, diabetes, and the insulin signaling pathway
Walaa I. El-Sofany, Tahani D Alanezi, Salman Latif, Ola Abdelhedi, Khaled Hamden
Topics & Concepts
In silicoInflammationProdigiosinDocking (animal)Diabetes mellitusEnzymeInsulin receptorMetabolic pathwayInsulinPharmacologyChemistryMedicineBioinformaticsBiologyInsulin resistanceBiochemistryBiotechnologyInternal medicineEndocrinologySerratia marcescensNursingEscherichia coliGeneMicrobial Metabolism and ApplicationsPharmacological Effects of Natural CompoundsMicrobial Natural Products and Biosynthesis